2023 ESC Guidelines: Management of Endocarditis
Guidelines for the Management of Endocarditis1) were presented at ESC Congress 2023, and guideline task force members, drs. Victoria Delgado and Michael A. Borger provided key points of revision.
The guidelines make 34 new recommendations for upgrading prophylactic antibiotic administration, new diagnostic criteria for infective endocarditis, outpatient intravenous antibiotic therapy (OPAT) and oral endocarditis treatment, and the timing and indications for surgery. The guidelines also emphasized the role of the endocarditis team and included recommendations for endocarditis teams.
- Prophylactic Antibiotic Therapy in High-Risk Patients
- Diagnostic Criteria for Infective Endocarditis
- Diagnostic Imaging of Infective Endocarditis Associated with Autologous Valves, Prosthetic Valves, and Implantable Cardiac Electrical Devices (CIEDs)
- Antibiotic Therapy
- Timing of Surgery for Infective Endocarditis
- Management of Infective Endocarditis Associated with CIEDs
Prophylactic Antibiotic Therapy in High-Risk Patients
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Recommendations
